Benign neoplasm: Duodenum

CD2_BENIGN_DUODENUM

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D13.2& Hospital discharge: ICD-8 — 21121 Cause of death: ICD-10 — D13.2& Cause of death: ICD-8 — 21121 2 out of 7 registries used, show all original rules.	852
4. Check minimum number of events None	852
5. Include endpoints None	852
6. Filter based on genotype QC (FinnGen only)	852

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D13
Name in latin: Neoplasma benignum duodeni

NAME	CD2_BENIGN_DUODENUM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D132
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21121
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D132
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21121
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Duodenum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Duodenum

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4501	2253	2225
Only index persons	4114	2085	2029
Unadjusted period prevalence (%)
Whole population	0.06	0.06	0.06
Only index persons	0.08	0.08	0.08
Median age at first event (years)
Whole population	66.66	66.94	66.36
Only index persons	66.34	66.64	66.04

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	852	447	405
Unadjusted period prevalence (%)	0.16	0.15	0.18
Median age at first event (years)	66.55	66.10	67.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
775: Matched controls
7750

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4503599627370496.0

323.0

764

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

26.6

307.3

679

1624

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

22.8

88.2

130

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

24.4

81.3

117

UJF32

NOMESCO Finland

Coloscopy

4.6

81.3

401

1471

JDH05

NOMESCO Finland

Endoscopic polypectomy in duodenum

+∞

57.0

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

38.3

45.1

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

59.2

42.9

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

6.3

42.4

120

218

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

37.0

40.9

A02BC02

ATC

pantoprazole; systemic

2.9

37.9

601

4182

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.4

35.3

113

237

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

9.1

35.3

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

3.9

34.8

159

477

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.8

34.2

163

507

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.7

32.9

122

299

JLC30

NOMESCO Finland

Pancreatoduodenectomy

36.0

32.2

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

31.1

335

1786

D64.9

ICD-10 Finland

Anaemia, unspecified

3.7

30.4

150

477

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.8

28.3

130

388

UJF92

NOMESCO Finland

Capsular endoscopy

8.9

27.8

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

14.9

26.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.4

26.4

143

484

A02BC05

ATC

esomeprazole; systemic

2.2

25.3

382

2338

WX002

NOMESCO Finland

Sedation and analgesia

2.6

24.6

225

1068

UJF30

NOMESCO Finland

Ileoscopy through colon

3.5

24.1

124

403

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.5

23.0

218

1047

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

26.8

22.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

22.3

416

2737

A02BC01

ATC

omeprazole; systemic

2.3

22.3

279

1537

A09AA02

ATC

multienzymes (lipase, protease etc.)

7.1

22.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

21.9

168

712

JFA05

NOMESCO Finland

Endoscopic polypectomy in small intestine

226.1

21.7

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

32.2

21.6

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

10.5

21.6

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

4.8

21.2

164

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

38.4

20.9

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

6.5

20.8

JDH52

NOMESCO Finland

Endoscopic mucosal or submucosal resection in duodenum

+∞

19.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.2

19.8

196

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

19.7

150

628

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4.6

19.4

161

UJF02

NOMESCO Finland

Peroral enteroscopy

18.8

19.2

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.1

19.2

112

396

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

18.9

212

1094

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

8.4

18.7

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

7.3

18.4

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

17.7

233

UJK02

NOMESCO Finland

ERCP

5.7

17.7

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

17.6

246

1394

JDH50

NOMESCO Finland

Local excision of lesion of duodenal bulb

184.0

17.6

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

17.2

205

1081

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

5.3

17.2

106

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

16.8

200

1052

UJD02

NOMESCO Finland

Gastroscopy

4.0

16.0

172

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

16.0

103

386

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.9

16.0

115

A02BC03

ATC

lansoprazole; oral

2.0

16.0

270

1640

K92.1

ICD-10 Finland

Melaena

3.7

15.7

207

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

15.2

318

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.3

15.2

251

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

8.7

15.1

WX402

NOMESCO Finland

General anaesthesia

2.3

15.1

150

719

Z2221

NOMESCO Finland

Medical doctor

2.0

15.0

240

1419

K30

ICD-10 Finland

Functional dyspepsia

2.6

14.8

111

460

ZX120

NOMESCO Finland

Intravenous

2.8

14.7

101

396

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

81.7

14.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

14.3

102

410

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

14.2

164

844

H02AB06

ATC

prednisolone; systemic

1.8

14.0

391

2794

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

13.9

156

791

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

30.6

13.9

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

13.9

175

936

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.5

13.9

201

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

24.3

13.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

13.8

116

510

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

13.8

251

1551

K22.1

ICD-10 Finland

Ulcer of oesophagus

5.9

13.8

JN4BD

NOMESCO Finland

Extensive body CT

2.4

13.7

124

568

R03AC02

ATC

salbutamol; inhalant

1.8

13.5

399

2897

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.7

13.2

101

J01DB01

ATC

cefalexin; oral

1.9

12.9

626

5295

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.8

12.8

SPAT1236

SPAT

Informing family of child’s disability

5.8

12.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

12.5

101

434

N02BE01

ATC

paracetamol; systemic, rectal

2.1

12.5

676

5910

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

13.5

12.5

AA1AD

NOMESCO Finland

CT of head and brain

1.9

12.4

227

1395

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

38.2

12.2

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

27.2

12.1

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.6

12.0

163

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

11.9

410

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

7.3

11.6

C07AB07

ATC

bisoprolol; oral

1.7

11.5

416

3146

JAH00

NOMESCO Finland

Laparotomy

4.4

11.5

R4110

NOMESCO Finland

Physiotherapy

1.8

11.4

231

1461

Z01.7

ICD-10 Finland

Laboratory examination

2.4

11.4

101

453

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

7.1

11.4

R06.0

ICD-10 Finland

Dyspnoea

1.8

11.3

220

1372

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

11.2

136

710

M79.6

ICD-10 Finland

Pain in limb

1.7

11.1

282

1915

ZXE00

NOMESCO Finland

One hour or less

1.7

11.1

315

2214

B01AB05

ATC

enoxaparin; parenteral

1.8

11.1

259

1714

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

11.1

105

491

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

11.1

506

4071

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

14.1

11.0

B80

ICPC

Iron deficiency anaemia

5.6

11.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

10.9

317

2241

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

21.8

10.7

K63.8

ICD-10 Finland

Other specified diseases of intestine

21.8

10.7

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

8.1

10.6

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

10.5

164

21121

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Duodeni

+∞

10.4

Z3226

NOMESCO Finland

Physiotherapist

1.9

10.4

166

963

K83.0

ICD-10 Finland

Cholangitis

8.4

10.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

10.3

209

1315

C03CA01

ATC

furosemide; systemic

1.7

10.3

256

1719

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

10.2

176

1051

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

10.1

124

647

3AC01

NOMESCO Finland

10.2

10.1

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.9

10.0

106

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.3

9.9

N02AA05

ATC

oxycodone; systemic

2.0

9.9

137

752

N05CF01

ATC

zopiclone; oral

1.7

9.9

266

1827

R4190

NOMESCO Finland

Nutritional therapy

4.1

9.8

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.2

9.6

473

WX892

NOMESCO Finland

Monitored bed care

2.5

9.6

331

Z51.88

ICD-10 Finland

Other specified medical care

4.9

9.5

N02AX02

ATC

tramadol; systemic, rectal

1.6

9.5

346

2568

N03AX16

ATC

pregabalin; oral

1.8

9.5

192

1205

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

9.5

420

R02

ICPC

Shortness of breath/dyspnoea

2.1

9.5

107

538

K29.4

ICD-10 Finland

Chronic atrophic gastritis

4.7

9.5

JDH28

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in duodenum

101.2

9.4

TJX22

NOMESCO Finland

Excision of local lesion in gastrointestinal endoscopy

+∞

9.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

9.4

137

767

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

9.3

349

D50.8

ICD-10 Finland

Other iron deficiency anaemias

5.8

9.3

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

9.2

143

816

Z3231

NOMESCO Finland

Registered nurse

1.7

9.2

228

1519

P01AB01

ATC

metronidazole; oral, rectal

1.6

9.2

295

2113

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

9.2

453

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.2

9.1

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

9.1

211

1379

D13.0

ICD-10 Finland

Benign neoplasm: Oesophagus

24.3

8.9

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.4

8.9

129

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.8

8.8

ZXA00

NOMESCO Finland

Right side

1.7

8.7

233

1583

A06AD11

ATC

lactulose; oral

1.9

8.7

132

749

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.6

8.6

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.6

8.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

8.6

341

2567

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

8.6

270

Z71.9

ICD-10 Finland

Counselling, unspecified

2.7

8.5

227

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

8.5

312

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

8.4

339

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

91.0

8.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

8.4

290

2107

J45

ICD-10 Finland

Asthma

2.3

8.3

376

R12

ICD-10 Finland

Heartburn

2.5

8.3

281

R03BA05

ATC

fluticasone; inhalant

1.9

8.3

134

776

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

5.0

8.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

8.2

147

881

JN4AD

NOMESCO Finland

Body CT examination

2.3

8.2

349

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.2

8.2

A46

ICD-10 Finland

Erysipelas

1.9

8.2

119

663

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

8.2

140

830

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

8.1

122

687

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

8.1

223

1521

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

8.1

204

1360

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.7

8.1

216

WX004

NOMESCO Finland

Patient-controlled sedation

10.2

8.1

A03FA02

ATC

cisapride; oral, rectal

2.2

8.0

369

C03DA01

ATC

spironolactone; oral

2.0

8.0

517

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

8.0

116

646

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.3

8.0

118

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

7.9

287

R51.80

ICD-10 Finland

Headache

2.0

7.9

106

572

K29.8

ICD-10 Finland

Duodenitis

6.7

7.9

WW500

NOMESCO Finland

Blood transfusion

3.0

7.8

143

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

7.8

115

J01FF01

ATC

clindamycin; systemic

1.7

7.8

205

1380

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

7.7

128

747

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.7

7.7

A02BC04

ATC

rabeprazole; oral

2.2

7.7

375

ZXD05

NOMESCO Finland

Urgent procedure

1.6

7.7

230

1599

JDA45

NOMESCO Finland

Endoscopic mucosal or submucosal resection in stomach or pylorus

45.4

7.7

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

7.5

7.7

A02BA02

ATC

ranitidine; systemic

1.7

7.7

173

1114

M04AA01

ATC

allopurinol; systemic

1.9

7.6

113

632

J45.8

ICD-10 Finland

Mixed asthma

3.8

7.6

K29.7

ICD-10 Finland

Gastritis, unspecified

3.0

7.6

140

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

12.0

7.6

N03AX12

ATC

gabapentin; oral

1.8

7.6

128

751

K22.7

ICD-10 Finland

Barrett oesophagus

5.8

7.6

R03DC03

ATC

montelukast; oral

1.9

7.5

114

646

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

7.2

7.5

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.6

7.4

A07AA02

ATC

nystatin; oral

2.4

7.4

257

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

5.4

7.4

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

7.8

7.4

R52.9

ICD-10 Finland

Pain, unspecified

2.2

7.4

346

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

13.5

7.4

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.4

7.4

L17

ICPC

Foot/toe symptom/complaint

1.6

7.4

197

1328

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.9

7.3

8140/3-C17.0

ICD-O-3

Adenocarcinoma, NOS, of duodenum

+∞

7.3

JDH00

NOMESCO Finland

Duodenotomy

+∞

7.3

N06AB04

ATC

citalopram; systemic

1.7

7.2

160

1021

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

7.2

434

OAB50

SPAT

4.9

7.2

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.9

7.2

151

J01MA12

ATC

levofloxacin; systemic

1.7

7.2

155

986

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

7.2

250

1805

M54.5

ICD-10 Finland

Low back pain

1.6

7.2

236

1680

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.6

7.1

Z50.1

ICD-10 Finland

Other physical therapy

2.5

7.1

220

B01AA03

ATC

warfarin; systemic

1.7

7.1

175

1155

K55.2

ICD-10 Finland

Angiodysplasia of colon

12.2

7.1

K85.8

ICD-10 Finland

Other acute pancreatitis

8.9

7.1

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.6

7.1

195

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

7.0

342

J46

ICD-10 Finland

Status asthmaticus

4.0

7.0

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

7.0

393

WZC30

SPAT

3.7

6.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

6.9

149

R13

ICD-10 Finland

Dysphagia

2.3

6.9

290

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

13.9

6.9

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

6.9

174

1156

J01FA06

ATC

roxithromycin; oral

1.5

6.8

294

2220

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.7

6.8

168

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.2

6.8

105

K59.0

ICD-10 Finland

Constipation

2.4

6.8

232

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

6.8

274

2042

A10BA02

ATC

metformin; oral

1.6

6.7

226

1612

JDH25

NOMESCO Finland

Other endoscopic haemostatic procedure in duodenum

22.7

6.7

A01

ICPC

Pain general/multiple sites

2.2

6.6

317

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

6.6

133

827

J01MA02

ATC

ciprofloxacin; systemic

1.5

6.6

298

2275

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.7

6.5

167

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.6

6.5

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.6

6.5

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.8

6.4

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

3.0

6.4

116

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

6.4

273

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

6.4

261

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.1

6.3

106

R01BA51

ATC

phenylpropanolamine, combinations; oral

2.0

6.3

404

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.0

6.3

112

M25.5

ICD-10 Finland

Pain in joint

1.6

6.3

193

1346

JFA73

NOMESCO Finland

Excision of lesion of small intestine

+∞

6.3

8240/3-C17.0

ICD-O-3

Neuroendocrine tumor, NOS, of duodenum

+∞

6.3

JKC50

NOMESCO Finland

Excision of papilla of Vater and anastomosis of bile duct to duodenum or jejunum

+∞

6.3

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.8

6.3

K83.1

ICD-10 Finland

Obstruction of bile duct

5.1

6.2

A10BH01

ATC

sitagliptin; oral

1.9

6.2

458

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

6.2

153

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

6.2

227

1648

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

6.2

161

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

6.2

307

WX110

NOMESCO Finland

Local anesthesy

1.5

6.1

480

4080

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

6.1

452

K55.8

ICD-10 Finland

Other vascular disorders of intestine

12.6

6.1

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

6.1

133

848

R03AC13

ATC

formoterol; inhalant

2.5

6.0

194

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

6.0

546

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

426

1066

6.99

177.53

2.4

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

223

747

3.69

55.81

3.0

2.1

g/l

0.2

0.76

210

698

(3024561) Albumin [Mass/volume] in Serum or Plasma

570

3382

3.07

52.09

8.5

4.8

g/l

34.3

35.1

2.71

543

3140

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

399

1961

2.95

51.64

3.3

2.2

mg/l

3.8

3.1

2.95

354

1670

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

629

3991

3.20

50.04

9.6

6.4

umol/l

13.0

11.7

0.56

613

3787

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

236

880

3.33

49.29

3.5

4.3

ug/l

8.7

24.9

0.89

191

744

(3032080) INR in Blood by Coagulation assay

550

3321

2.85

46.41

12.8

9.9

inr

1.3

0.01

119

908

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

126

322

4.42

45.52

3.1

3.4

u/ml

28.3

1347.3

1.54

101

276

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

438

2396

2.70

44.24

4.8

2.4

u/l

55.9

57.4

0.32

421

2202

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

193

681

3.37

43.61

3.9

2.4

u/l

58.1

41.1

0.46

179

574

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

215

835

3.11

41.17

4.8

2.8

umol/l

9.4

8.6

0.11

193

728

(3000570) Elastase.pancreatic [Mass/mass] in Stool

233

4.57

37.71

1.6

1.5

ug/g

208.9

280.9

2.87

143

(3022948) Iron [Moles/volume] in Serum or Plasma

269

1234

2.72

37.41

3.7

2.5

umol/l

10.9

12.6

3.45

253

1144

(3013826) Glucose [Moles/volume] in Serum or Plasma

643

4456

2.81

37.41

7.7

5.0

mmol/l

6.8

0.42

612

4207

(3004789) Transferrin [Mass/volume] in Serum or Plasma

252

1137

2.73

36.03

3.8

2.4

g/l

2.3

0.34

233

1061

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

243

1077

2.76

35.97

3.8

2.5

19.2

22.4

2.51

207

923

(3022145) Colonoscopy Study observation

199

831

2.82

32.70

1.5

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

404

2381

2.33

31.50

4.2

2.5

—

(3019198) Lymphocytes [#/volume] in Blood

543

3633

2.36

31.27

7.5

5.7

e9/l

1.7

1.9

2.26

494

3191

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

520

3424

2.33

30.97

7.1

4.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

216

966

2.66

30.86

2.7

2.6

1.9

1.8

0.59

199

863

(3001604) Monocytes [#/volume] in Blood

534

3560

2.34

30.83

7.4

5.7

e9/l

0.6

0.03

479

3071

(3006315) Basophils [#/volume] in Blood

535

3573

2.34

30.70

7.5

5.7

e9/l

0.0

0.77

480

3090

(3001122) Ferritin [Mass/volume] in Serum or Plasma

469

2965

2.29

30.68

4.9

2.7

ug/l

105.0

151.5

4.57

430

2694

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

387

2269

2.29

30.21

5.0

3.2

u/l

32.2

33.3

0.33

370

2154

(3013115) Eosinophils [#/volume] in Blood

546

3693

2.33

30.19

7.8

5.9

e9/l

0.2

1.00

495

3237

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

168

4.66

29.80

2.9

3.6

u/ml

438.7

2162.4

0.59

161

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

736

5733

3.08

29.65

12.6

7.8

u/l

89.5

79.3

2.21

716

5364

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

562

3890

2.31

28.78

9.7

6.9

mmol/l

1.2

2.55

500

3300

(3013650) Neutrophils [#/volume] in Blood by Automated count

589

4162

2.35

28.66

10.6

9.2

e9/l

4.5

4.2

2.69

538

3651

(3023368) Bacteria identified in Blood by Culture

371

2214

2.20

26.91

6.0

4.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

114

389

3.23

26.49

1.8

2.0

g/l

1.6

1.5

0.30

340

(3018010) Neutrophils/100 leukocytes in Blood

498

3361

2.16

26.04

7.4

5.8

59.2

58.0

1.61

466

3135

(3002030) Lymphocytes/100 leukocytes in Blood

502

3416

2.14

25.46

7.7

6.0

25.4

26.7

2.18

471

3168

(3019069) Monocytes/100 leukocytes in Blood

496

3361

2.14

25.42

7.8

6.2

8.7

8.8

0.36

468

3139

(3006504) Eosinophils/100 leukocytes in Blood

492

3341

2.12

24.85

7.5

5.8

3.0

2.8

0.74

460

3102

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

481

3252

2.10

24.42

2.6

2.1

pmol/l

90.8

94.8

1.17

284

1661

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

141

572

2.76

23.96

2.1

1.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

426

2794

2.05

23.02

4.6

3.3

—

(3033658) Prothrombin time (PT) actual/Normal

322

1910

2.10

22.83

6.9

3.9

84.7

87.8

1.24

315

1866

(3022096) Basophils/100 leukocytes in Blood

475

3252

2.04

22.65

7.4

5.8

0.7

0.34

446

3025

(3002032) Base excess in Venous blood by calculation

168

765

2.49

22.48

4.8

3.5

mmol/l

1.6

2.0

0.81

143

614

(3019309) Folate [Moles/volume] in Red Blood Cells

278

1571

2.14

22.29

1.8

nmol/l

1248.4

1194.1

0.40

221

1167

(3003458) Phosphate [Moles/volume] in Serum or Plasma

207

1042

2.30

22.07

7.0

5.5

mmol/l

1.0

0.44

190

953

(3013707) Erythrocyte sedimentation rate by Westergren method

681

5373

2.33

21.85

5.5

4.3

mm/h

15.8

13.4

2.81

635

4927

(3023520) Reticulocytes [#/volume] in Blood

162

738

2.48

21.60

2.5

2.7

e9/l

73.0

70.3

0.29

122

581

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

192

954

2.31

21.00

8.3

7.4

kpa

5.1

0.12

183

913

(3027801) Oxygen [Partial pressure] in Arterial blood

192

955

2.30

20.94

8.3

7.4

kpa

11.6

11.9

0.41

183

917

(3012095) Magnesium [Moles/volume] in Serum or Plasma

234

1264

2.17

20.85

4.0

3.3

mmol/l

0.8

0.23

217

1180

(3048689) Calprotectin [Mass/mass] in Stool

163

757

2.43

20.78

1.8

2.2

ug/g

149.2

146.7

0.04

135

589

(3042936) Bacteria identified in Isolate by Culture

216

1133

2.21

20.70

2.6

2.0

—

(3003396) Base excess in Arterial blood by calculation

191

954

2.29

20.60

8.2

7.4

mmol/l

1.1

1.2

0.19

157

744

(40758558) Short blood count panel - Blood

306

1844

2.03

20.28

8.1

6.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

300

1817

2.00

19.44

4.3

2.5

—

(3000850) Epithelial cells [#/volume] in Urine

280

1657

2.03

19.35

3.2

2.6

e6/l

4.3

5.0

0.67

244

1462

(36304419) Bacteria [Presence] in Urine

331

2082

1.96

19.18

4.3

3.2

—

(3030467) Casts [#/volume] in Urine by Automated count

342

2178

1.95

19.08

4.3

3.2

e6/l

0.8

0.5

0.48

287

1670

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

497

3583

1.93

19.05

9.5

6.1

mmol/l

1.2

3.95

467

3226

(3020779) Urea [Moles/volume] in Serum or Plasma

149

695

2.39

18.68

8.9

6.9

mmol/l

10.2

10.3

0.05

144

659

(42870588) Differential panel, method unspecified - Blood

372

2450

1.92

18.66

7.2

5.7

—

(3000991) Gas panel - Venous blood

146

676

2.40

18.61

8.5

8.6

—

(3018418) pH of Serum or Plasma

356

2323

1.91

18.27

6.2

4.1

7.4

0.72

437

(3002173) Hemoglobin [Mass/volume] in Arterial blood

162

796

2.28

17.96

9.2

8.1

g/l

116.9

120.4

1.31

156

768

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

178

912

2.20

17.82

4.3

4.2

u/l

229.6

244.8

1.41

167

867

(3018095) Leukocytes [#/volume] in Urine

396

2695

1.88

17.67

5.0

3.8

e6/l

35.1

86.5

3.76

316

1970

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

255

1502

2.00

17.58

5.5

4.1

ng/l

129.6

373.4

2.65

214

1243

(3002582) Erythrocytes [#/volume] in Urine

355

2345

1.88

17.30

4.4

3.4

e6/l

28.6

92.9

1.51

302

1832

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

235

1352

2.02

17.27

3.2

2.9

e6/l

2.6

1.1

0.55

152

801

(3021589) Normoblasts [#/volume] in Blood

443

3145

1.85

17.09

13.1

10.0

e9/l

0.0

0.45

381

2600

(3026782) Osmolality of Urine

258

1542

1.97

16.95

3.4

2.9

mosm/kgh2o

510.9

553.8

2.35

221

1317

(3021960) Folate [Moles/volume] in Serum or Plasma

309

1964

1.90

16.87

1.8

1.6

nmol/l

22.1

20.9

0.30

271

1643

(3007853) Bacteria identified in Skin by Aerobe culture

168

875

2.15

16.00

2.2

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

418

2969

1.80

15.61

2.9

2.3

nmol/l

76.0

79.1

1.42

377

2602

(3005719) IgG [Mass/volume] in Serum or Plasma

122

562

2.37

15.60

2.2

2.6

g/l

10.3

10.6

0.30

114

511

(3037522) Nuclear Ab [Titer] in Serum

171

906

2.11

15.54

1.4

1.3

titre

401.8

447.2

0.19

200

(40768804) Tissue Pathology biopsy report

409

2899

1.79

15.27

2.6

2.2

—

(3019060) Gas panel - Arterial blood

121

564

2.33

15.04

7.4

4.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

366

2524

1.79

14.89

3.6

3.1

ng/l

2021.1

1383.7

0.92

318

2169

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

340

2.67

14.63

2.5

1.9

ug/l

3.7

2.2

0.45

300

(3028026) IgM [Mass/volume] in Serum or Plasma

101

445

2.44

14.22

1.7

1.8

g/l

1.3

1.6

0.73

406

(3015377) Calcium [Moles/volume] in Serum or Plasma

380

2676

1.76

14.19

3.1

3.6

mmol/l

2.3

2.4

2.03

339

2303

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

792

7028

2.80

14.17

31.0

15.9

mg/l

26.1

25.4

0.24

705

5647

(3026008) Bacteria identified in Urine by Culture

347

2384

1.77

14.10

3.7

3.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

139

708

2.15

13.89

3.8

3.1

ng/l

230.1

224.9

0.04

127

650

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

562

4438

1.78

13.88

5.1

3.2

u/l

75.1

53.8

2.74

525

4084

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

345

2381

1.75

13.69

2.3

2.2

u/l

257.0

236.5

0.09

327

2238

(3037467) Urinalysis macro (dipstick) panel - Urine

621

5064

1.83

13.62

5.5

4.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

111

521

2.30

13.53

9.1

9.3

0.6

0.7

1.70

111

516

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

169

937

2.00

13.42

2.4

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

169

940

2.00

13.29

2.5

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

109

3.80

13.05

1.5

1.6

g/l

0.9

0.8

0.08

(3020630) Protein [Mass/volume] in Serum or Plasma

135

698

2.11

12.93

2.5

3.0

g/l

65.6

66.4

0.53

124

633

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

110

526

2.25

12.81

9.0

9.1

1.4

0.02

110

521

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

382

2.45

12.77

5.3

3.6

mmol/l

23.6

24.3

1.23

345

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

644

5356

1.83

12.67

4.8

3.9

pmol/l

15.0

0.15

591

4783

(3008152) Bicarbonate [Moles/volume] in Arterial blood

111

538

2.22

12.51

11.3

6.5

mmol/l

24.0

24.5

0.47

106

504

(3007164) IgA [Mass/volume] in Serum or Plasma

209

1272

1.85

12.46

1.5

g/l

2.7

2.5

0.50

128

754

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

401

2.39

12.33

3.8

2.5

0.7

0.42

389

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

206

1252

1.85

12.32

3.6

3.1

e6/l

2.9

2.2

0.43

127

706

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

212

1306

1.83

12.12

2.4

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

467

3578

1.68

12.11

4.7

3.9

estimate

0.0

0.00

671

(3021601) Nitrite [Presence] in Urine by Test strip

467

3583

1.67

12.00

6.7

5.3

estimate

0.0

0.00

672

(3012516) Albumin [Mass/volume] in Urine

334

2354

1.69

11.85

3.2

3.3

mg/l

1037.5

309.9

1.07

226

1497

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

244

1581

1.76

11.72

2.0

1.6

mg/l

1.3

0.08

191

1226

(3022217) INR in Platelet poor plasma by Coagulation assay

184

1095

1.87

11.71

34.6

29.1

inr

1.3

0.17

128

(3009261) Glucose [Presence] in Urine by Test strip

469

3623

1.66

11.56

4.9

3.9

estimate

0.0

0.50

655

(3017143) Hepatitis C virus Ab [Presence] in Serum

123

640

2.08

11.54

1.8

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

406

3035

1.65

11.31

5.2

3.9

ng/l

48.0

53.2

0.09

316

2278

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

127

679

2.02

11.05

1.8

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

449

2.23

10.94

1.2

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

385

2.31

10.78

4.4

3.7

47.8

48.8

0.15

380

(3020891) Body temperature

334

2.40

10.73

9.0

4.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

286

1976

1.67

10.70

3.5

2.7

umol/l

363.8

8699.9

8.88

251

1674

(3044889) 12 lead EKG panel

622

5224

1.71

10.62

5.3

4.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

134

743

1.95

10.49

3.1

2.6

ug/l

5.5

7.2

0.90

120

654

(3023183) Ammonium ion [Moles/volume] in Plasma

172

2.90

10.17

5.3

2.8

umol/l

36.3

33.1

0.31

145

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

230

2.63

10.15

1.6

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

226

1485

1.71

10.11

5.0

4.7

—

(3025941) Bacteria identified in Stool by Culture

384

2.26

10.01

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

404

2.20

9.61

2.8

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

111

597

1.99

9.45

2.1

2.6

—

(4010399)

106

561

2.02

9.44

1.6

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

455

2.12

9.44

9.8

9.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

339

2506

1.59

9.36

3.9

4.0

mg/mmol

22.0

8.3

2.27

221

1575

(3027273) Bicarbonate [Moles/volume] in Venous blood

412

2.15

9.15

4.1

3.2

mmol/l

24.8

25.2

0.41

401

(3002385) Erythrocyte distribution width [Ratio]

655

5666

1.67

9.04

36.6

19.7

14.4

13.8

14.16

649

5554

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

168

2.77

8.87

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

168

2.77

8.87

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

438

2.10

8.86

6.6

8.4

mmol/l

25.5

25.1

0.57

433

(3004716) Salmonella sp identified in Stool by Organism specific culture

317

2.28

8.81

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

233

1593

1.64

8.79

5.7

4.4

kg/l

1.0

2.74

232

(3014765) Yersinia sp identified in Stool by Organism specific culture

235

2.48

8.75

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

212

1417

1.66

8.74

1.3

1.2

u/ml

3.1

1.8

0.22

375

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

483

2.04

8.72

1.9

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

421

2.10

8.66

7.7

10.4

mmol/l

24.3

24.6

0.50

396

(3018405) Lactate [Moles/volume] in Arterial blood

313

2.27

8.65

7.0

3.5

mmol/l

1.6

1.4

0.47

306

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

227

1549

1.63

8.61

3.2

mmol/l

2.5

0.07

203

1362

(3019550) Sodium [Moles/volume] in Serum or Plasma

800

7390

2.35

8.57

36.0

19.0

mmol/l

139.2

139.6

4.64

788

7195

(3011397) Hemoglobin [Presence] in Urine by Test strip

246

1715

1.61

8.54

4.6

3.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

238

2.45

8.52

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

801

7409

2.36

8.45

36.0

19.1

mmol/l

4.0

0.81

787

7206

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

234

2.44

8.35

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

112

630

1.90

8.34

5.3

3.7

ng/l

115.3

86.6

2.04

551

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

181

1174

1.69

8.32

1.3

iu/ml

41.4

35.9

0.18

393

(3009508) Creatinine [Moles/volume] in Urine

324

2422

1.54

8.26

3.1

3.2

mmol/l

7.3

0.03

264

1995

(3024139) IgG subclass 3 [Mass/volume] in Serum

3.83

8.11

1.2

1.3

g/l

0.5

0.05

(3028192) IgG subclass 2 [Mass/volume] in Serum

3.83

8.11

1.2

1.3

g/l

2.9

0.05

(3027135) IgG subclass 1 [Mass/volume] in Serum

3.83

8.11

1.2

1.3

g/l

7.1

7.6

0.20

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.64

8.04

3.7

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

279

2.28

7.89

2.7

3.8

mg/l

126.7

74.4

0.33

220

(46235355) HIV 1 and 2 tests - Meaningful Use set

129

772

1.79

7.87

1.9

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

280

2.27

7.82

2.7

3.8

mg/l

37.9

40.8

0.08

223

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

112

3.02

7.73

1.3

1.4

u/ml

130.5

105.1

1.30

(4062490)

3.66

7.62

1.2

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

271

2.26

7.56

3.4

2.5

u/ml

0.3

0.4

0.27

150

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

4.67

7.43

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

171

1125

1.65

7.38

1.3

u/ml

38.6

11.9

0.48

409

(3036489) Thrombin time

248

2.30

7.36

2.1

2.0

22.3

21.8

0.27

224

(40761535) Cells panel - Urine sediment

114

671

1.81

7.34

4.6

3.6

—

(44806118)

3.29

7.30

1.9

1.6

—

(44790048)

3.29

7.30

1.9

1.6

—

(44790047)

3.29

7.30

1.9

1.6

—

(44790049)

3.29

7.30

1.9

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

105

606

1.84

7.20

2.8

ml/min/173m2

51.1

61.2

1.95

257

(3036481) Cortisol [Moles/volume] in Serum or Plasma

114

675

1.80

7.19

2.5

2.1

nmol/l

318.9

372.6

2.12

101

620

(3042733) HLA Ab [Presence] in Serum

6.95

7.16

2.9

5.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

214

2.37

7.06

2.2

4.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

134

839

1.71

6.95

1.6

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

715

6459

1.67

6.90

6.1

4.8

mu/l

1.9

2.2

0.64

664

5806

(3021879) Hepatitis B virus core Ab [Presence] in Serum

404

1.97

6.69

1.5

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

247

2.22

6.58

1.5

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

123

2.75

6.57

1.2

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

215

2.31

6.54

2.8

2.6

ug/min

214.2

88.9

0.56

124

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

2.59

6.52

5.2

6.0

iu/ml

90.4

142.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

3.19

6.48

1.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

231

1679

1.52

6.41

1.9

1.7

pmol/l

464.4

17037475.7

1.30

204

1350

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

2.05

6.40

2.6

g/l

4.0

3.7

0.45

234

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

326

2.04

6.35

2.6

g/l

7.5

7.4

0.09

241

(3024891) Influenza virus A+B Ag [Presence] in Specimen

163

2.46

6.20

1.3

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

326

2.01

5.99

2.7

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

172

2.39

5.99

1.4

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

305

2.04

5.99

2.6

2.7

g/l

9.7

10.2

0.29

260

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

102

2.80

5.84

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

181

2.33

5.80

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

345

2757

1.42

5.74

5.5

4.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

159

2.39

5.57

1.7

1.6

—

(3024471) HLA-A [Type]

5.29

5.53

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

147

2.44

5.53

1.1

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.28

5.47

1.5

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

410

1.85

5.47

1.2

1.4

—

43.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

118

2.60

5.43

1.4

1.3

—

(4094501)

207

2.19

5.38

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

222

2.13

5.28

1.5

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

177

2.26

5.20

1.7

—

(40761511) CBC panel - Blood by Automated count

774

7250

1.74

5.19

30.6

15.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

2.84

5.18

1.3

1.2

u/ml

89.7

75.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1.95

5.10

2.8

2.7

g/l

3.2

3.1

0.27

238

(3052851) Hemolysis interference index of Serum or Plasma

226

2.09

5.06

3.7

3.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

289

1.97

5.04

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.94

5.00

2.1

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.94

5.00

2.3

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

677

6169

1.47

4.93

34.5

17.5

37.7

39.2

2.74

416

4032

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

791

7471

1.82

4.93

17.9

11.3

u/l

26.8

25.7

0.93

775

7174

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

431

3644

1.37

4.87

2.9

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

216

2.09

4.86

2.0

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.83

4.82

2.2

1.7

16.2

13.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

280

1.95

4.80

2.7

3.0

g/l

0.7

1.3

0.69

244

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

3.20

4.78

1.2

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

368

1.83

4.77

3.0

3.2

pmol/l

4.2

4.5

1.69

314

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

144

1005

1.52

4.72

16.2

8.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

511

1.69

4.58

1.8

1.6

—

(3024932) HLA-DR beta [Type]

4.81

4.54

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

196

2.09

4.46

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

721

6692

1.50

4.42

8.4

6.4

mmol/mol

41.5

40.5

1.79

670

6127

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

119

809

1.55

4.40

4.3

3.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.77

4.37

3.0

2.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

113

2.43

4.35

2.2

2.7

—

(36660697) Celiac disease serology panel - Serum

481

1.68

4.29

1.2

—

(4035726)

102

679

1.57

4.13

1.3

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

103

688

1.57

4.11

2.1

1.8

1.5

1.47

576

(3002256) Pathology report gross observation

133

940

1.49

4.10

1.4

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

311

1.82

4.08

1.6

2.1

u/l

36.6

38.9

0.33

274

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

260

1.90

4.07

2.9

2.7

g/l

36.5

37.4

0.45

221

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

111

2.38

4.03

1.1

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

106

2.40

3.93

1.1

1.2

u/ml

312.6

301.9

0.06

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

2.64

3.83

1.2

u/l

56.9

52.3

0.22

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.37

3.77

2.5

2.6

u/ml

582.5

1256.1

1.22

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.43

3.75

1.4

1.2

u/ml

2.0

2.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.48

3.74

2.5

2.2

—

(3033799) Differential panel - Peritoneal fluid

4.04

3.70

3.6

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

111

2.29

3.58

2.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

145

2.11

3.51

1.8

1.6

—

(3000494) Fungus identified in Specimen by Culture

125

905

1.45

3.41

1.9

1.4

—

(3000492) Spirometry study

618

1.53

3.40

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.86

3.37

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

410

0.43

3.35

1.4

—

(3000330) Specific gravity of Urine by Test strip

410

1.63

3.32

4.6

4.0

—

(3007461) Platelets [#/volume] in Blood

801

7693

1.69

3.32

46.6

23.6

e9/l

249.6

244.3

1.21

787

7480

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

2.11

3.31

1.5

—

(3035941) MCH [Entitic mass]

801

7694

1.69

3.30

46.3

23.5

30.1

30.4

4.73

794

7564

(3024731) MCV [Entitic volume]

801

7694

1.69

3.30

46.3

23.5

91.0

91.5

1.76

794

7565

(3010813) Leukocytes [#/volume] in Blood

801

7695

1.68

3.29

46.6

23.7

e9/l

7.1

6.8

3.26

783

7460

(3026361) Erythrocytes [#/volume] in Blood

801

7695

1.68

3.29

46.5

23.6

e12/l

4.3

4.4

7.13

782

7461

(1761482) Bacteria [#/volume] in Urine by Culture

220

1.86

3.28

5.1

5.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

288

1.74

3.25

2.6

3.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

801

7698

1.68

3.24

47.0

23.8

g/l

128.5

134.2

16.34

793

7564

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

157

2.01

3.23

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

2.76

3.16

1.3

1.1

nmol/l

1.6

0.00

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.76

3.16

2.3

—

(3047181) Lactate [Moles/volume] in Blood

253

1.78

3.15

10.0

6.2

mmol/l

1.6

1.3

0.67

224

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

180

1.93

3.14

1.3

1.2

u/ml

1.9

3.0

—

(3017704) Immunofixation for Urine

2.83

3.10

2.3

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

232

1.81

3.09

1.7

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

112

2.18

3.09

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

153

2.00

3.08

1.5

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

182

1.90

3.05

1.3

1.2

u/ml

2.1

3.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

2.92

3.03

1.2

1.3

promille

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

101

2.21

2.95

1.5

1.3

e6/l

1515.9

1831.9

0.25

(3003327) Ova and parasites identified in Stool by Light microscopy

200

1.84

2.89

1.7

1.6

—

(3013512) EKG study

281

2363

1.28

2.87

4.8

4.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.70

2.87

2.0

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

6.70

2.87

1.8

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.22

2.85

1.5

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.37

2.83

2.2

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

103

2.17

2.82

1.7

—

(44813793)

2.79

2.82

1.2

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.25

2.82

1.4

1.3

e6/l

154261.6

183465.8

0.09

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

2.42

2.81

1.4

1.1

u/ml

1.3

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

2.49

2.80

1.3

1.0

u/ml

1.1

4.4

—

(3029937) Albumin [Presence] in Urine by Test strip

239

1975

1.29

2.79

5.4

4.2

estimate

0.0

0.69

641

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.29

2.79

2.2

2.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.53

2.71

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.68

2.63

1.5

u/l

5.6

10.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

261

1.68

2.59

1.6

—

126.7

—

(4306422)

2.21

2.59

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

228

1889

1.28

2.58

4.6

3.6

—

(3017732) Neutrophils [#/volume] in Blood

462

1.51

2.58

2.0

2.9

e9/l

4.1

4.2

0.06

344

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

420

0.51

2.56

2.3

1.8

—

(40768441) Liver Pathology biopsy report

2.44

2.55

1.6

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.05

2.53

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.05

2.53

1.1

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2.19

2.52

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.48

2.46

1.4

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.96

2.42

1.0

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

2.09

2.38

1.3

1.2

u/ml

16.6

6.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

132

1.92

2.38

1.6

1.8

—

(3017181) Myelocytes/100 leukocytes in Blood

649

1.41

2.37

4.5

4.0

1.6

1.0

0.28

193

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.14

2.36

1.1

—

(3003694) ABO and Rh group [Type] in Blood

214

1778

1.27

2.35

1.5

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.88

2.31

1.0

2.5

u/l

260.8

213.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

399

1.51

2.31

2.9

e6/l

0.1

0.2

0.94

390

(3012441) Differential panel - Pleural fluid

2.14

2.30

1.3

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

654

1.40

2.27

3.6

3.7

mmol/l

1.2

0.10

571

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.36

2.22

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

107

1.99

2.22

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.80

2.20

1.3

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

730

6975

1.33

2.20

5.8

5.0

mmol/l

6.3

6.0

3.73

665

6262

(3003181) Sodium [Moles/volume] in Urine

136

1.86

2.20

1.6

1.3

mmol/l

62.2

62.0

0.01

117

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

166

1.77

2.17

1.7

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

116

1.92

2.12

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.58

2.10

1.3

1.1

u/l

23.6

17.3

0.35

(40768443) Skin Pathology biopsy report

334

1.53

2.09

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

717

1.37

2.08

1.6

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.52

2.06

1.6

4.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

118

1.89

2.03

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

2.24

2.01

1.4

1.1

u/ml

0.5

0.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.16

1.99

1.8

1.4

14.0

31.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.57

1.94

1.4

umol/l

52.4

35.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.46

1.93

1.3

1.1

u/l

75.5

81.3

0.20

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.75

1.93

1.2

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

150

1.76

1.92

3.2

2.1

69.6

61.0

1.01

150

(3000093) Morphology [Interpretation] in Blood Narrative

2.07

1.92

1.1

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

700

6681

1.27

1.91

24.8

15.0

ml/min/173m2

75.1

75.9

0.43

618

5548

(3023419) Bacteria identified in Sputum by Culture

121

1.84

1.90

4.2

2.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.33

1.88

1.2

1.1

—

(3034426) Prothrombin time (PT)

3.20

1.88

1.1

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.04

1.86

1.6

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

262

1.55

1.85

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.93

1.81

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.77

1.79

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

216

1.60

1.79

1.4

1.5

iu/ml

0.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

185

1.64

1.77

1.5

1.4

—

(1616796) Gas panel - Central venous blood

147

1.72

1.75

4.2

4.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

606

1.35

1.74

4.7

4.1

0.3

0.1

0.25

172

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.52

1.74

1.6

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

3.86

1.71

1.6

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.86

1.71

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.89

1.71

4.3

3.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.81

1.65

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

579

1.34

1.61

4.1

4.0

0.6

0.00

137

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.51

1.60

2.6

1.7

ug/l

35.0

55.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.71

1.58

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.71

1.58

6.6

2.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.12

1.55

1.4

1.3

u/l

15.9

13.3

0.36

(3027315) Oxygen [Partial pressure] in Blood

161

1.63

1.54

6.2

4.5

kpa

8.6

8.4

0.27

156

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.88

1.51

1.3

1.2

nmol/l

—

(3025159) Blasts/100 leukocytes in Blood

568

1.33

1.50

4.0

4.2

0.0

0.7

0.64

146

(3021901) Oxygen saturation in Capillary blood

139

1.67

1.49

2.9

3.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

203

1.55

1.47

3.5

3.2

nmol/l

0.8

0.26

164

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

379

1.40

1.46

1.3

1.2

iu/ml

86.8

137.5

1.02

146

(3024928) Oxygen saturation in Venous blood

188

1.56

1.44

3.1

2.6

—

(3010421) pH of Blood

205

1.53

1.42

6.2

4.0

7.4

0.65

155

(3001019) Free T4 and TSH panel - Serum or Plasma

225

0.53

1.42

1.8

1.7

—

(3045788) Cell count panel - Pleural fluid

1.87

1.40

1.5

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.19

1.40

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.19

1.40

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

223

1.50

1.38

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.84

1.36

1.3

mmol/l

6.7

6.3

0.28

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.95

1.36

1.6

1.2

—

(3044941) Cell count panel - Synovial fluid

128

1.66

1.34

1.9

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.15

1.34

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.15

1.34

1.4

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

161

1.57

1.30

6.1

4.5

kpa

5.0

0.02

156

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.37

1.29

1.4

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

138

1.61

1.27

1.2

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.06

1.27

2.9

3.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.41

1.24

1.5

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.78

1.23

1.7

1.9

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1.98

1.22

1.5

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.12

1.18

7.8

5.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.12

1.18

1.1

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

510

1.30

1.17

3.9

kpa

5.1

5.2

0.15

472

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

110

1.65

1.16

1.6

2.1

30.6

32.5

0.95

110

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1.70

1.14

1.6

54.0

63.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

282

0.63

1.13

1.7

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

192

1.47

1.12

2.3

1.7

e6/l

17991.8

17861.5

0.01

140

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

478

1.30

1.12

4.0

3.9

mmol/l

1.5

2.1

0.43

366

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.68

1.10

2.0

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.74

1.09

1.2

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.83

1.09

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.66

1.07

1.1

—

20.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.77

1.07

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.77

1.07

1.5

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.77

1.07

1.6

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.77

1.07

1.5

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.13

1.05

1.6

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.80

1.05

2.0

1.4

—

(3037756) Immunofixation for Serum or Plasma

196

1.44

1.03

1.7

—

(40768806) Pleura Pathology biopsy report

1.66

1.01

1.5

1.6

—

(4268621)

1.78

1.01

2.0

2.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.63

1.00

1.6

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

2.01

1.00

1.7

1.2

mmol/l

6.1

6.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

131

0.53

0.99

1.1

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.18

0.98

1.4

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.18

0.98

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.95

0.97

1.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

100

1.61

0.97

1.7

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

100

1.61

0.97

1.7

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.86

0.97

1.3

1.1

—

(3017569) Oxygen content in Arterial blood

1.81

0.97

2.2

1.8

—

(3051651) Icteric interference index of Serum or Plasma

1.81

0.97

2.2

3.0

—

(3035880) pH of Pleural fluid

1.81

0.97

1.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.90

0.94

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.90

0.94

1.4

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

101

1.60

0.94

1.7

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

101

1.60

0.94

1.7

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

101

1.60

0.94

1.7

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.15

0.91

1.0

1.3

mmol/l

2.2

3.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

110

1.56

0.91

2.5

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.91

0.88

3.0

1.3

g/l

0.9

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

731

7135

1.17

0.88

6.1

5.4

mmol/l

2.4

2.7

7.42

657

6462

(3006462) Nitrate [Presence] in Urine

2.01

0.87

2.5

2.9

—

(3037121) Protein [Mass/volume] in Urine

273

1.33

0.87

2.9

3.1

g/l

0.5

0.2

0.79

107

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

711

6929

1.16

0.85

5.3

4.7

mmol/l

1.4

1.5

5.44

636

6255

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.68

0.85

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.63

0.85

1.8

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.60

0.84

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

688

6692

1.15

0.84

4.9

4.2

mmol/l

1.4

1.3

1.37

614

5991

(3004809) Band form neutrophils/100 leukocytes in Blood

122

1.49

0.80

5.5

3.7

0.8

1.3

0.56

102

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

1.52

0.79

1.3

1.5

—

(3011648) Oxygen content in Venous blood

1.68

0.79

1.4

1.6

14.0

10.5

3.34

(21494434) Karyotype in Bone marrow

1.59

0.78

1.1

1.3

—

(4211845)

1.77

0.76

2.5

2.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.09

0.74

1.0

miu/ml

3050.6

1537.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.09

0.74

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.64

0.73

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.63

0.72

1.0

—

(3024263) Appearance of Synovial fluid

1.76

0.71

1.9

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.76

0.71

1.4

1.3

—

(40768800) Prostate Pathology biopsy report

182

0.65

0.71

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

101

1.49

0.70

1.8

1.4

—

(1761868) Lipid panel - Serum or Plasma

206

2238

0.90

0.70

3.6

3.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.56

0.70

1.4

1.7

—

(4281824)

1.57

0.68

1.7

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.86

0.68

4.8

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.67

0.68

1.1

1.2

—

(3022313) Gas panel - Capillary blood

375

1.24

0.68

4.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

120

1.43

0.65

2.6

1.4

mu/l

283.4

273.8

0.05

111

(3044290) Cell count panel - Cerebral spinal fluid

138

1.39

0.63

1.4

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

1.64

0.62

2.9

1.7

—

31.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

165

1.34

0.61

1.0

1.1

—

8.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

122

1.40

0.60

1.6

1.2

u/l

16.4

10.5

0.44

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.60

0.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.60

0.0

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

1.51

0.60

2.5

3.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.54

0.59

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.58

0.0

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

184

1.31

0.58

1.6

1.3

mg/l

538.9

520.8

0.12

171

(3021788) Differential panel - Synovial fluid

149

1.35

0.58

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

288

2715

1.09

0.58

5.0

5.4

ug/l

2.0

3.0

1.69

250

2409

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

274

1.25

0.57

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.49

0.57

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.49

0.57

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.49

0.57

1.4

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.67

0.56

1.3

—

(3022621) pH of Urine by Test strip

514

1.18

0.56

3.1

3.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.46

0.56

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.46

0.56

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.46

0.56

1.4

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.63

0.55

1.0

1.1

—

8.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

146

1592

0.90

0.54

3.1

3.2

ug/l

0.6

0.8

1.83

111

1104

(4146454)

1.42

0.54

3.5

2.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

711

6980

1.11

0.54

5.4

4.8

mmol/l

4.3

4.6

11.01

640

6354

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

323

1.22

0.53

4.3

mmol/l

24.7

25.2

0.37

301

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.49

0.47

1.0

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.49

0.47

1.0

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

300

1.21

0.47

1.8

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

1.48

0.47

1.6

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.40

0.45

3.0

2.1

—

(3011288) Drugs identified in Urine by Screen method

1.45

0.44

1.2

2.0

—

(3020650) Glucose [Presence] in Urine

0.00

0.40

0.0

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

169

1.25

0.39

2.7

2.4

g/l

122.2

127.4

0.54

127

(3051593) INR in Capillary blood by Coagulation assay

1.39

0.38

12.6

11.7

—

(3025130) Human papilloma virus identified in Specimen

1.40

0.35

1.8

1.7

—

(3004451) EKG impression Narrative

1.37

0.34

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

986

0.91

0.33

4.7

4.9

32.6

32.5

0.03

640

(40767503) Oxygen content in Capillary blood by calculation

164

1.22

0.33

3.5

2.8

16.0

15.8

0.10

(3023410) Appearance of Cerebral spinal fluid

1.36

0.32

1.9

1.3

—

(3045142) Bone marrow Pathology biopsy report

1.31

0.32

1.9

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

152

0.79

0.29

1.1

1.2

—

(1002224) Polysomnography panel

238

0.84

0.29

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.23

0.29

1.0

1.1

—

(3008898) HLA-B27 [Presence]

186

1.19

0.28

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.27

0.26

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

339

1.13

0.26

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

513

1.10

0.24

2.1

2.2

nmol/l

15.9

13.1

0.32

445

(40761536) Microorganisms panel - Urine sediment

618

0.92

0.23

4.1

4.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

162

1.18

0.23

1.6

iu/l

5.8

5.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

227

2193

1.05

0.23

4.8

4.6

19.6

21.4

1.24

115

1117

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.28

0.23

5.0

5.2

—

38.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.25

0.22

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.25

0.22

1.6

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.19

0.21

2.0

2.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

3.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

5.7

—

(44806071)

0.00

0.21

0.0

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

0.21

0.0

1.0

—

6.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.21

0.0

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.21

0.0

2.7

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.21

0.0

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.16

0.21

1.0

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.16

0.21

1.0

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.16

0.21

1.0

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.16

0.21

1.0

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

3.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.21

0.0

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.25

0.20

1.8

2.4

13.2

13.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.25

0.20

1.8

1.9

—

(3044927) Protein electrophoresis panel - Urine

108

1.21

0.20

1.1

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.15

0.19

1.0

1.3

—

51.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

121

0.82

0.18

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

119

1.18

0.17

1.6

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

1.11

0.17

1.7

2.0

ug/l

2.5

3.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

312

1.09

0.16

1.9

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

140

1.15

0.15

3.2

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.11

0.15

1.0

1.5

—

(3045414) Leukocytes [Presence] in Urine

326

1.08

0.12

2.1

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

807

1.05

0.12

1.6

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

203

1986

1.03

0.12

1.6

1.7

mmol/l

1.4

0.39

182

1643

(3004616) Nuclear Ab [Presence] in Serum

1.16

0.11

1.5

1.2

—

(3049717) Cytology report of Urine Cyto stain

348

1.07

0.10

3.5

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

115

1.13

0.10

1.2

1.1

—

(3014271) Vancomycin [Susceptibility]

1.06

0.09

3.2

2.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

282

1.07

0.09

1.9

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.11

0.09

1.2

—

81.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.11

0.09

2.3

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

136

1.10

0.08

2.9

3.5

58.5

58.7

0.02

136

(3003740) Influenza virus B Ag [Presence] in Specimen

0.79

0.08

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.78

0.08

1.0

1.1

—

(4024509)

0.77

0.08

2.4

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.86

0.07

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1.03

0.07

1.0

—

1.6

—

(3019225) pH of Specimen

806

0.98

0.04

4.9

4.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

131

1.07

0.03

2.6

3.2

e9/l

4.2

4.5

0.17

131

(40768793) Breast Pathology biopsy report

177

0.96

0.01

1.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

106

0.94

0.01

1.1

1.5

—

(3027008) Opiates [Presence] in Urine

106

0.94

0.01

1.1

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

136

0.96

0.00

1.4

—

(3042631) Mycobacterium sp identified in Specimen

122

0.98

0.00

1.8

2.7

—

(3014051) Protein [Presence] in Urine by Test strip

178

1.01

0.00

2.3

2.2

—

(4034850)

242

0.99

0.00

12.1

11.7

—

(3000764) Benzodiazepines [Presence] in Urine

105

0.95

0.00

1.1

1.5

—

(3027944) Amphetamines [Presence] in Urine

105

0.95

0.00

1.1

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

185

1.03

0.00

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.5

—

12.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3005570) Glucose [Moles/volume] in Urine

1.01

0.00

1.3

2.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.4

—

1.7

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

2.7

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.96

0.00

2.2

1.7

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

0.92

0.00

7.0

3.3

mg/l

19.8

15.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

3.3

—

(3016879) Cocaine [Presence] in Urine

100

1.00

0.00

1.1

1.5

—

(3020491) Glucose [Moles/volume] in Blood

0.98

0.00

1.5

2.8

mmol/l

6.7

7.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

2.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.96

0.00

3.8

4.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_DUODENUM and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_DUODENUM	1.736 [1.49, 2.02]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.143

During the follow-up period (1.1.1998 — 31.12.2019), 518 out of 1933 females with CD2_BENIGN_DUODENUM died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_DUODENUM	2.001 [1.7, 2.36]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 669 out of 1893 males with CD2_BENIGN_DUODENUM died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_DUODENUM.

N-year risk	Females	Males
1	0.129%	0.405%
5	0.957%	2.134%
10	2.273%	5.405%
15	4.66%	10.356%
20	8.151%	16.828%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_DUODENUM – Benign neoplasm: Duodenum

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Duodenum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints